Roche Holding Tightens Consultancy Spending Controls

Roche Holding has announced measures to limit its spending with the Big Four accounting firms, requiring future consultancy work to receive pre-approval from the company's chief financial officer. Bloomberg posted on X, detailing the Swiss drugmaker's decision as part of its broader efforts to manage costs effectively. This move reflects Roche's strategic approach to financial oversight and resource allocation, ensuring that consultancy engagements align with its business objectives. The decision underscores the importance of maintaining fiscal discipline in the pharmaceutical industry, where operational efficiency is crucial for sustaining competitive advantage.